Pure Global

Behavioral Activation for Depression and Habitual Rumination - Trial NCT06322420

Access comprehensive clinical trial information for NCT06322420 through Pure Global AI's free database. This phase not specified trial is sponsored by Ragnar Pétur Ólafsson and is currently Recruiting. The study focuses on Major Depressive Disorder. Target enrollment is 130 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06322420
Recruiting
behavioral
Trial Details
ClinicalTrials.govNCT06322420
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Behavioral Activation for Depression and Habitual Rumination
Mood-reactive Habitual Rumination and Changes During Behavioral Activation Treatment for Major Depression

Study Focus

Major Depressive Disorder

Behavioural Activation (BA)

Interventional

behavioral

Sponsor & Location

Ragnar Pétur Ólafsson

University of Iceland

Reykjavík, Iceland

Timeline & Enrollment

N/A

Feb 09, 2024

Feb 01, 2026

130 participants

Primary Outcome

Symptom severity measured by the BDI-2,Disorder severity assessed with the DIAMOND diagnostic interview - Major Depressive Disorder,Diagnostic status assessed with the DIAMOND diagnostic interview - Major Depressive Episode

Summary

Depressive rumination, a negative thinking style characterized by repetitive and passive
 thoughts about the causes, meanings, and consequences of one's feelings and distress, is
 often described as being a habitual response tendency that forms a vulnerability to
 depression. Behavioural Activation (BA) is an effective treatment for depression but little
 is known of mechanisms of changes during a successful treatment completion and for whom the
 treatment benefits the most. The main purpose of the study is to investigate whether
 habit-like mood-reactive rumination will change during Behavioral Activation treatment for
 current depression and mediates symptom changes in the treatment. Important moderators of
 change will also be investigated (i.e. history of early life stress and cognitive
 flexibility). We aim to provide individual BA treatment for up to 130 currently depressed
 participants in 12 treatment sessions over 11 weeks. Measures are obtained at pre-treatment,
 during treatment, at post-treatment and at 6 month follow up.

ICD-10 Classifications

Recurrent depressive disorder
Recurrent depressive disorder, unspecified
Depressive conduct disorder
Other recurrent depressive disorders
Recurrent depressive disorder, current episode moderate

Data Source

ClinicalTrials.gov

NCT06322420

Non-Device Trial